Fundraising Overview - The company raised a total of RMB 754.56 million through the issuance of 32 million shares at a price of RMB 23.58 per share, with a net amount of RMB 685.86 million after deducting underwriting fees [1] - As of December 31, 2023, the cumulative amount directly invested in fundraising projects was RMB 285.64 million, with an unutilized amount of RMB 438.47 million [2] Fund Utilization in 2024 - In 2024, the company utilized RMB 284.99 million of the raised funds, including expenditures for various projects such as RMB 0.79 million for the automated production base and RMB 18.01 million for acquiring equity in Hongtong Technology [3] - By December 31, 2024, the total amount directly invested in fundraising projects reached RMB 570.63 million, with an unutilized balance of RMB 158.55 million [3][4] Fund Management and Storage - The company established a dedicated account for the management and storage of raised funds, ensuring compliance with relevant regulations and protecting investor interests [4][5] - As of December 31, 2024, the total balance in the fundraising special account was RMB 77.15 million, which included cash management products [6] Changes in Fund Usage - The company approved changes in the use of funds, reallocating RMB 18.01 million from the automated production base project to acquire a 60% stake in Hongtong Technology [8][19] - Additionally, RMB 15.49 million was reallocated to increase capital for Hongtong Technology's factory capacity enhancement in Thailand [19] Idle Fund Management - The company decided to use up to RMB 300 million of idle funds for cash management, investing in low-risk, liquid financial products [6][14] - As of December 31, 2024, the cash management products balance was RMB 81.40 million, which included RMB 34.40 million in seven-day notice deposits and RMB 47 million in large time deposits [6][14] Fund Usage Reporting - The company confirmed that all disclosed information regarding the use of raised funds is timely, accurate, and complete, complying with relevant laws and regulations [24] - The special report on fundraising was approved by the board on April 28, 2025 [25]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002099 证券简称：海翔药业 公告编号：2025-012 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求 （2022年修订）》（证监会公告〔2022〕15号）和深圳证券交易所印发的《深圳证券交易所上市公司自 律监管指引第1号——主板上市公司规范运作（2023年12月修订）》（深证上〔2023〕1145号）的规 定，将本公司募集资金2024年度存放与使用情况专项说明如下。 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会证监许可〔2016〕765号文核准，并经深圳证券交易所同意，本公司由主承 销商国泰君安证券股份有限公司采用非公开发行方式，向特定对象非公开发行人民币普通股（A股）股 票9,989.0023万股，发行价为每股人民币10.28元，共计募集资金102,686.94万元，坐扣承销和保荐费用 1,000万元后的募集资金为101,686.94万元，已由主承销商国泰君安证 ...

Core Viewpoint - Zhejiang Zhengte Co., Ltd. reported a net profit of -13,981,036.69 yuan for the year 2024, leading to a proposal not to distribute profits for that year [8][9]. Financial Data - The company confirmed that it does not need to restate previous accounting data [3]. - The total undistributed profits as of December 31, 2024, amounted to 363,294,206.32 yuan, while the parent company reported a net profit of 108,725,995.47 yuan [8][9]. - The company plans to carry forward the accumulated undistributed profits to meet operational needs [9]. Asset Impairment - For the year 2024, the company recognized an asset impairment loss of 3,135,700 yuan, which includes credit impairment losses of 2,682,600 yuan and asset impairment losses of 581,800 yuan [16]. - In the first quarter of 2025, the company recorded an asset impairment loss of 11,751,600 yuan, with credit impairment losses of 9,008,100 yuan and asset impairment losses of 2,743,500 yuan [41]. Daily Related Transactions - The company anticipates daily related transactions with a total amount not exceeding 30 million yuan for 2025, based on the execution of 17,540,500 yuan in actual transactions in 2024 [19][20]. - The company has established relationships with several related parties, including Zhejiang Zhengte Gaoxiu Garden Materials Co., Ltd., which is a joint venture [20][25]. Compensation Plan - The proposed compensation plan for directors, supervisors, and senior management for 2025 includes a pre-tax allowance of 60,000 yuan per year for independent directors, with other directors and senior management receiving salaries based on their positions [31][34]. - The compensation will be linked to the company's long-term development and annual performance [32]. Annual Performance Meeting - The company will hold an annual performance meeting on May 9, 2025, to communicate with investors and address their concerns [47][49]. - Investors can submit questions before the meeting through designated online platforms [48].

Core Viewpoint - Tianfulong Group's IPO has been approved, but the company faces challenges such as declining profit margins, increasing inventory, and reduced fundraising, which may affect investor confidence post-listing [3][4][9]. Financial Performance - Tianfulong's main business involves the R&D, production, and sales of differentiated polyester short fibers, with revenue projected to grow from 2.576 billion yuan in 2022 to 3.841 billion yuan in 2024, and net profit expected to rise from 358 million yuan to 454 million yuan during the same period [4]. - Despite revenue and net profit growth, the company's gross profit margin has decreased from 18.86% in 2022 to 16.50% in 2024, a decline of 2.36 percentage points [4]. Tax Incentives - The increase in net profit is largely attributed to tax incentives, including VAT refunds, which contributed 63 million yuan, 54 million yuan, and 87 million yuan to net profit in 2022, 2023, and 2024, respectively, accounting for 16.05%, 11.68%, and 17.77% of net profit [5]. Inventory and Receivables - Tianfulong's inventory has surged from 398 million yuan in 2022 to 660 million yuan in 2024, representing 12.34% and 17.05% of total assets, respectively [8]. - The accounts receivable turnover ratio for Tianfulong was 14.02 times in 2022, compared to industry peers' ratios of 32.69 times and 26.49 times in 2022 and 2023, indicating weaker performance in managing receivables [7]. IPO Fundraising Changes - Initially, Tianfulong aimed to raise 1.09 billion yuan, but later reduced the fundraising target to 790 million yuan by eliminating a 300 million yuan project for supplementing working capital, raising questions about the necessity of this funding [9][10]. - The company has sufficient cash reserves, with bank deposits increasing from 483 million yuan in 2022 to 752 million yuan in 2024, suggesting that the need for additional working capital may not be justified [10].

Group 1 - The company Wuhan Feien Microelectronics Co., Ltd. specializes in the design, manufacturing, and sales of pressure sensors, tire pressure monitoring systems, MEMS products, electronic and optoelectronic products, and automotive components [1] - The company Zhejiang Cuizhan Microelectronics Co., Ltd. focuses on the sales and design of integrated circuits, semiconductor devices, and electronic materials [2] - The company has a registered capital of 59.81 million RMB and is involved in various electronic and software services [2] Group 2 - Ningbo Tianlong Electronics Co., Ltd. plans to use idle funds for entrusted wealth management, with a maximum daily balance of 400 million RMB [8][11] - The company aims to enhance the value of idle funds while ensuring normal business operations and liquidity [10][15] - The board of directors has approved the wealth management plan, which does not require shareholder meeting approval [12] Group 3 - The company intends to engage in foreign exchange derivative transactions to mitigate exchange rate risks, with a cumulative limit of 20 million USD [18][20] - The transactions will include forward foreign exchange contracts and options, focusing on risk management rather than speculative trading [22][24] - The board has approved the foreign exchange derivative trading plan, which is valid for 12 months [24] Group 4 - The company has announced a ticket pool business with a maximum balance of 200 million RMB, aimed at optimizing cash flow management [39][42] - The ticket pool will be managed by a reputable commercial bank, providing services such as verification and collection [39][41] - The board has authorized the chairman to execute necessary agreements for the ticket pool business, pending shareholder approval [48] Group 5 - The company has reported a total impairment provision of 13.47 million RMB for the year 2024, reflecting a cautious approach to asset valuation [51][56] - The impairment includes provisions for credit losses on receivables and inventory write-downs [52][53] - The audit committee supports the impairment provisions, stating they align with accounting standards and do not harm shareholder interests [57]

登录新浪财经APP 搜索【信披】查看更多考评等级 附表2 募集资金使用情况对照表（2022年非公开发行募集资金） 2024年1-12月 编制单位：上海璞泰来新能源科技股份有限公司 单位：人民币万元 ■ 证券代码：603659 证券简称：璞泰来 公告编号：2025-034 上海璞泰来新能源科技股份有限公司 关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ●拟聘任的会计师事务所：安永华明会计师事务所（特殊普通合伙） 2025年4月25日，上海璞泰来新能源科技股份有限公司（以下简称"公司"）召开第四届董事会第五次会 议，审议通过了《关于续聘会计师事务所的议案》，同意续聘安永华明会计师事务所（特殊普通合伙） （以下简称"安永华明"）为公司2025年度财务审计机构和内部控制审计机构，聘任期限为一年，并同意 提交公司股东大会审议，现将相关事项公告如下： 一、拟聘任会计师事务所的基本情况 （一）机构信息 1、基本信息 安永华明会计师事务所（特殊普通合伙）于1992年9月成立，2012年8月完成本土 ...

Core Viewpoint - The company plans to recognize an asset impairment provision totaling 78.06 million yuan for the first quarter of 2025, reflecting a proactive approach to financial management and transparency [7][9]. Financial Data Summary - The financial statements for the first quarter of 2025 are unaudited, and the company has confirmed the accuracy and completeness of the financial information provided [3][6]. - The company reported a total asset impairment provision of 78.06 million yuan, which will reduce the consolidated profit for the first quarter by the same amount [9]. Impairment Provision Details - The breakdown of the impairment provision includes: - 227,300 yuan for notes receivable based on a credit loss rate of 0.5% [7]. - 76.73 million yuan for accounts receivable, categorized into five groups based on credit risk characteristics [7][8]. - 1.08 million yuan for other receivables [8]. - 26,000 yuan for contract assets [8]. - A reversal of 5,200 yuan for inventory write-downs due to improved net realizable value [8]. Impact on Financial Position - The recognition of the impairment provision is expected to provide a more accurate representation of the company's financial status, while the overall financial condition remains stable with sufficient liquidity [9].

登录新浪财经APP 搜索【信披】查看更多考评等级 经审议，公司董事会定于2025年5月16日召开公司2024年年度股东大会。 具体内容详见公司在《证券时报》《中国证券报》《上海证券报》《证券日报》和巨潮资讯网 （www.cninfo.com.cn）披露的《关于召开2024年年度股东大会的通知》。 三、备查文件 1、公司第三届董事会第十八次会议决议； 2、公司第三届董事会第十九次会议决议。 特此公告。 深圳市金奥博科技股份有限公司 董事会 2025年4月25日 证券代码：002917 证券简称：金奥博 公告编号：2025-031 深圳市金奥博科技股份有限公司 关于召开2024年年度股东大会的 通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 深圳市金奥博科技股份有限公司(以下简称"公司")于2025年4月24日召开第三届董事会第十九次会议审 议通过了《关于提请召开2024年年度股东大会的议案》，决定于2025年5月16日召开公司2024年年度股 东大会（以下简称"本次股东大会"）。现将本次股东大会有关事项通知如下： 一、召开会议的基本情况 （2）网络投票时间 ...

Core Viewpoint - The company has disclosed its fundraising and usage status for the year 2024, indicating compliance with regulatory requirements and no misuse of funds [5][7][8]. Fundraising and Usage Summary - The company did not have any excess funds from its fundraising activities, nor were there any funds used for ongoing or new projects [1]. - As of December 31, 2024, there were no surplus funds allocated to other fundraising projects or non-fundraising projects [2]. - There was an incident where non-fundraising funds of 500,000 yuan mistakenly entered the fundraising account but were subsequently corrected [3]. - The company did not change the use of fundraising projects during the year [4]. - The company has adhered to the relevant regulations regarding the management and usage of fundraising, ensuring timely and accurate disclosures [5]. Audit and Verification - Tianzhi International Accounting Firm conducted a special audit of the company's fundraising report and confirmed that it reflects the actual situation fairly [6]. - The sponsor institution verified that the company's fundraising practices complied with all relevant laws and regulations, with no misuse of funds reported [7]. Financial Performance and Impairment - The company reported a total impairment provision of 451,243,534.53 yuan for the year 2024, primarily due to uncertainties in the collection of electricity fees from certain customers [24][27]. - This impairment provision will reduce the company's consolidated profit by the same amount, reflecting a cautious approach to financial reporting [27].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603267 证券简称：鸿远电子 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 单位:元 币种:人民币 ■ 对公司将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的，以及将《公开发行证券的公司信息披露解释性公告第1号一一非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目，应说明原因。 □适用 √不适用 (三)主要会计数据、财务指标发生变动的情况、原因 √适用 □不适用 ■ ■ (二)非经常性损益项目和金额 √适用 □ ...